Studies have indicated that HDGF expression is regarded as a prognostic factor in patients with early-stage NSCLC [6]; HDGF also promotes chemotherapy resistance in some tumors, including colorectal cancer, tongue squamous cell cancer, and breast cancer [25–27]. This evidence concerns the gene HDGF and breast cancer.